Cellular and Physiological Nutrition/Metabolism
Clinical and Translational Nutrition
Tzu-Wen Cross, PhD (she/her/hers)
Associate Professor
Department of Nutrition Science
Purdue University
West Lafayette, Indiana, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Chaoran Ma, MD, PhD (she/her/hers)
Assistant Professor
University of Massachusetts, Amherst
Amherst, Massachusetts, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Carrie Daniel-MacDougall, PhD, MPH
Professor, Dept of Epidemiology, Division of Cancer Prevention and Population Sciences
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Nancy Emenaker, PhD, MEd, RDN, LD, FAND (she/her/hers)
Program Official
National Cancer Institute, National Institutes of Health
Bethesda, Maryland, United States
Disclosure(s): No relevant financial relationship(s) with ineligible companies to disclose.
Cynthia Sears, MD (she/her/hers)
Professor of Medicine, Oncology and Molecular Microbiology & Immunology
Department of Medicine, School of Medicine
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States
Disclosure(s): Up to Date: Royalties or Patent Beneficiary (Ongoing)
Vedanta: Grant/Research Support (Ongoing)
This session will highlight cutting-edge research demonstrating how diet-microbiome interactions influence cancer risk, progression, and patient outcomes, including modulation of immune responses and variability in treatment response. Speakers will discuss mechanistic insights, translational applications, and population-level implications, spanning preclinical models, clinical studies, and large-scale epidemiologic investigations. A dedicated perspective from the National Institutes of Health will further contextualize funding priorities and future research directions in this rapidly evolving field.